Tech Company Financing Transactions

Fate Therapeutics Funding Round

Fate Therapeutics, based in San Diego, raised $10.3 million from private investors.

Transaction Overview

Company Name
Announced On
8/24/2016
Transaction Type
Venture Equity
Amount
$10,290,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3535 General Atomics Ct. 200
San Diego, CA 92121
USA
Email Address
Overview
Better Cells for Better Therapies We combine a deep understanding of hematopoietic cell biology with an unmatched expertise in programming cell function and fate. We believe the biological properties of immune cells can be modulated outside the body to impart profound therapeutic effects inside the body upon their administration to a patient.
Profile
Fate Therapeutics LinkedIn Company Profile
Social Media
Fate Therapeutics Company Twitter Account
Company News
Fate Therapeutics News
Facebook
Fate Therapeutics on Facebook
YouTube
Fate Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Scott Wolchko
  Scott Wolchko LinkedIn Profile  Scott Wolchko Twitter Account  Scott Wolchko News  Scott Wolchko on Facebook
Chief Scientific Officer
Daniel Shoemaker
  Daniel Shoemaker LinkedIn Profile  Daniel Shoemaker Twitter Account  Daniel Shoemaker News  Daniel Shoemaker on Facebook
Vice President
Sarah Cooley
  Sarah Cooley LinkedIn Profile  Sarah Cooley Twitter Account  Sarah Cooley News  Sarah Cooley on Facebook
VP - Bus. Development
James Beitel
  James Beitel LinkedIn Profile  James Beitel Twitter Account  James Beitel News  James Beitel on Facebook
VP - Bus. Development
Robert Valamehr
  Robert Valamehr LinkedIn Profile  Robert Valamehr Twitter Account  Robert Valamehr News  Robert Valamehr on Facebook
VP - General Counsel
Cindy Tahl
  Cindy Tahl LinkedIn Profile  Cindy Tahl Twitter Account  Cindy Tahl News  Cindy Tahl on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/24/2016: Virtru venture capital transaction
Next: 8/24/2016: Tempered Networks venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary